Transcatheter devices used in the management of patients with congenital heart disease.
The availability of transcatheter devices has revolutionized the management of patients with congenital heart and vascular disease. Many patients that were in the past exclusively treated through open heart surgical procedures can now be managed using a percutaneous approach. This article describes those devices that are, at present, most frequently used in the USA for transcatheter therapy of congenital heart disease, which have, or are about to receive, US premarket approval. It also focuses on devices for occlusion of septal defects and vascular structures, as well as endovascular stents. In addition, the most important outcome data are discussed.
Holzer
Ralf J
RJ
Heart Center, Columbus Children's Hospital, 700 Children's Drive, Columbus, OH 43205, USA. rholzer@chi.osu.edu
Chisolm
Joanne
J
Hill
Sharon L
SL
Cheatham
John P
JP
D006328:Cardiac Catheterization / Q000295:instrumentation* / Q000379:methods; D002986:Clinical Trials as Topic; D004867:Equipment Design; D006330:Heart Defects, Congenital / Q000628:therapy*; D006343:Heart Septal Defects / Q000628:therapy; D006801:Humans; D015607:Stents